Growth Metrics

Nektar Therapeutics (NKTR) Shares Issued (2016 - 2025)

Historic Shares Issued for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $238000.0.

  • Nektar Therapeutics' Shares Issued changed N/A to $238000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $456000.0, marking a year-over-year decrease of 9848.06%. This contributed to the annual value of $30.0 million for FY2024, which is 9990000.0% up from last year.
  • Nektar Therapeutics' Shares Issued amounted to $238000.0 in Q3 2025.
  • Nektar Therapeutics' Shares Issued's 5-year high stood at $30.0 million during Q1 2024, with a 5-year trough of $7000.0 in Q1 2025.
  • Over the past 5 years, Nektar Therapeutics' median Shares Issued value was $238000.0 (recorded in 2025), while the average stood at $5.0 million.
  • In the last 5 years, Nektar Therapeutics' Shares Issued soared by 9026.78% in 2021 and then plummeted by 9997.67% in 2025.
  • Over the past 5 years, Nektar Therapeutics' Shares Issued (Quarter) stood at $1.8 million in 2021, then crashed by 94.28% to $103000.0 in 2022, then crashed by 88.35% to $12000.0 in 2023, then soared by 249900.0% to $30.0 million in 2024, then plummeted by 99.21% to $238000.0 in 2025.
  • Its Shares Issued was $238000.0 in Q3 2025, compared to $211000.0 in Q2 2025 and $7000.0 in Q1 2025.